Total Payments
$1,494
2024 Payments
$305.15
Companies
22
Transactions
71
Medicare Patients
3,777
Medicare Billing
$912,965
Payment Breakdown by Category
Food & Beverage$1,399 (93.6%)
Education$95.06 (6.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,399 | 59 | 93.6% |
| Education | $95.06 | 12 | 6.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $437.83 | 17 | $0 (2024) |
| Relypsa, Inc. | $178.61 | 10 | $0 (2020) |
| Amgen Inc. | $141.17 | 7 | $0 (2024) |
| NXSTAGE MEDICAL, INC. | $100.32 | 1 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $94.41 | 3 | $0 (2020) |
| BTG International, Inc. | $94.12 | 1 | $0 (2017) |
| Keryx Biopharmaceuticals, Inc. | $66.58 | 4 | $0 (2018) |
| Bayer Healthcare Pharmaceuticals Inc. | $53.91 | 3 | $0 (2024) |
| Travere Therapeutics, Inc. | $52.91 | 10 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $41.45 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $305.15 | 17 | NXSTAGE MEDICAL, INC. ($100.32) |
| 2023 | $330.69 | 17 | AstraZeneca Pharmaceuticals LP ($254.99) |
| 2022 | $64.44 | 3 | AstraZeneca Pharmaceuticals LP ($50.87) |
| 2021 | $101.88 | 6 | Bayer HealthCare Pharmaceuticals Inc. ($30.15) |
| 2020 | $138.45 | 6 | Relypsa, Inc. ($90.04) |
| 2019 | $135.31 | 5 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($46.00) |
| 2018 | $112.50 | 4 | AstraZeneca Pharmaceuticals LP ($61.71) |
| 2017 | $305.21 | 13 | BTG International, Inc. ($94.12) |
All Payment Transactions
71 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/06/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 09/04/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 08/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: DIABETES | ||||||
| 08/13/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 07/18/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 07/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/29/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Cardio-renal | ||||||
| 04/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/24/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.66 | General |
| 03/12/2024 | NXSTAGE MEDICAL, INC. | NXSTAGE SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $100.32 | General |
| Category: Nephrology | ||||||
| 02/28/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $13.66 | General |
| 01/24/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 01/04/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.66 | General |
| 12/14/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/07/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Education | Cash or cash equivalent | $13.60 | General |
| Category: Nephrology | ||||||
| 11/06/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/04/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.66 | General |
| 09/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $29.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/06/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.66 | General |
| 08/01/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.66 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 847 | 1,898 | $802,101 | $227,128 |
| 2022 | 14 | 965 | 2,079 | $802,342 | $234,412 |
| 2021 | 13 | 1,000 | 2,134 | $743,995 | $249,998 |
| 2020 | 14 | 965 | 1,865 | $642,346 | $201,426 |
Total Patients
3,777
Total Services
7,976
Medicare Billing
$912,965
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 49 | 338 | $308,294 | $95,349 | 30.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 183 | 536 | $109,505 | $33,385 | 30.5% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 19 | 129 | $97,850 | $28,010 | 28.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 88 | 187 | $57,428 | $17,728 | 30.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 153 | 292 | $97,779 | $16,522 | 16.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 72 | 72 | $32,240 | $9,588 | 29.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 72 | 81 | $27,315 | $8,120 | 29.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 17 | 23 | $17,484 | $5,305 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $16,062 | $4,337 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 41 | $9,734 | $2,324 | 23.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 17 | 37 | $4,625 | $1,446 | 31.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 17 | 35 | $4,620 | $1,441 | 31.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 22 | 26 | $4,785 | $1,399 | 29.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 24 | 25 | $8,302 | $1,170 | 14.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 22 | 22 | $5,211 | $744.10 | 14.3% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 17 | 17 | $867.00 | $260.16 | 30.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 57 | 275 | $249,975 | $80,993 | 32.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 240 | 687 | $122,973 | $38,570 | 31.4% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 16 | 115 | $86,710 | $27,033 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 152 | 344 | $113,176 | $21,271 | 18.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 94 | 181 | $46,698 | $14,708 | 31.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 84 | 86 | $42,828 | $13,424 | 31.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 27 | 42 | $31,668 | $10,484 | 33.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 89 | 99 | $33,660 | $10,180 | 30.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 52 | 52 | $22,256 | $6,633 | 29.8% |
About Eric Yan
Eric Yan is a Nephrology healthcare provider based in Menifee, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225115892.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Eric Yan has received a total of $1,494 in payments from pharmaceutical and medical device companies, with $305.15 received in 2024. These payments were reported across 71 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,399).
As a Medicare-enrolled provider, Yan has provided services to 3,777 Medicare beneficiaries, totaling 7,976 services with total Medicare billing of $912,965. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Menifee, CA
- Active Since 11/01/2006
- Last Updated 08/10/2021
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1225115892
Products in Payments
- FARXIGA (Drug) $265.35
- Veltassa (Drug) $202.32
- LOKELMA (Drug) $110.77
- NXSTAGE SYSTEM ONE (Device) $100.32
- LifeVest (Device) $94.41
- CROFAB (Drug) $94.12
- Parsabiv (Biological) $86.44
- Auryxia (Drug) $66.58
- BRILINTA (Drug) $61.71
- Kerendia (Drug) $53.91
- ACTHAR (Biological) $27.38
- Sensipar (Drug) $24.88
- SAMSCA (Drug) $22.60
- IBSRELA (Drug) $22.53
- AURYXIA (Drug) $21.59
- JYNARQUE (Drug) $18.85
- Ozempic (Drug) $17.63
- JARDIANCE (Drug) $17.41
- KRYSTEXXA (Biological) $17.18
- INJECTAFER (Drug) $16.55
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.